Status:
TERMINATED
CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies
Lead Sponsor:
Johns Hopkins University
Conditions:
Inflammatory Myelopathies
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This research is being done to see how different amounts of Functional Electrical Stimulation (FES) affect cycling on factors in blood and spinal cord in people with spinal cord inflammation.
Detailed Description
FES cycling is a method of applying low level electrical currents to the leg and buttock muscles to cause the weakened or paralyzed muscles to contract and produce a cycling motion of the legs. The FE...
Eligibility Criteria
Inclusion
- Male, Female, age 18-65, all ethnic groups
- History of inflammatory myelopathy with onset at least 3 months prior
- No FES ergometer (i.e. RT300 or equivalent) use within 1 month
- Subject is medically stable, with no recent (1 month or less) inpatient admission for acute medical or surgical issues
- Subject is legally able to make own health care decisions
- Access to telephone with texting capabilities
- English language proficiency
Exclusion
- Cardiovascular disease as defined by previous myocardial infarction, unstable angina, requirement for anti platelet agents, congestive heart failure, or stroke New York Heart Association (NYHA) Class III or IV, history of arrhythmia with hemodynamic instability.
- Uncontrolled hypertension (resting systolic BP\>160mmHg or diastolic BP \>100mmHg consistently)
- Concurrent lower motor neuron disease such as peripheral neuropathy that would exclude lower extremity electrical excitability
- Unstable long bone fractures of the lower extremities
- Subjects who are unwilling to agree to two cerebrospinal fluid (CSF) examinations (lumbar punctures)
- Presence of cardiac pacemaker and/or defibrillator
- Presence of cancer
- History of epileptic seizures
- Subjects having a Stage 2 or greater sacral decubitus ulcer
- Women who are pregnant
- Active drug or alcohol use or dependence
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01440452
Start Date
November 1 2010
End Date
July 1 2019
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Neurorehabilitation Institute
Lutherville, Maryland, United States, 21093